Site Search

… is truly exciting.” Translating these findings into viable therapeutics will be a journey of exploration, demanding …

… is well known, for instance, for having co-founded Seaside Therapeutics to spur development and testing of a promising … in-house clinical testing, Tsai also co-founded Cognito Therapeutics to spur larger-scale testing and development of … and memory. That was licensed by a company called Rodin Therapeutics. Newton Professor Mriganka Sur has also watched …

… these is a phase 3 clinical trial by the company Cognito Therapeutics, which has licensed MIT’s technology. That study …

… that A11 acts via a distinct mechanism from existing AD therapeutics, A11 could be used alone or in combination with approved therapeutics to provide improved treatment options for …

… Prescott said. “Our hope is to use these insights to build therapeutics that could halt or reverse airway scarring, or …

… metabolomics in neurodegenerative diseases, to potential therapeutics, such as gene therapies, or sensory stimulation …